The Tech Interactive Announces Seismic Valley: The Earthquake Experience, Coming Summer 2027 
Islamic Finance Takes Center Stage as a Driver of Sustainable Economic Growth at Global Forum 
OMP and Eastman Show Decision Velocity in Practice at Gartner Supply Chain Planning Summit 2026 T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in…
Oncternal Therapeutics Presents Rationale and Plans for its Registrational Phase 3 Study Evaluating Zilovertamab in Combination with Ibrutinib at the EHA 2022 Congress
SAN DIEGO, June 10, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
ABVC BioPharma Announces Termination of Two Contracts
FREMONT, CA, June 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
ORYZON at EHA-2022: Iadademstat 42-month ALICE Data Demonstrate Robust Efficacy in Combination with Azacitidine in AML
81% of evaluable patients achieved an objective response Deep responses: 64% are CR/CRi, of which…
GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific Killer Engager (TriKE®) Driving Robust NK Cell Function Against B Cell Malignancies at EHA 2022 Congress
Ongoing experiments will evaluate the functionality and efficacy of GTB-7550 in vivo Future studies will…
Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA
Multiplex deletion of myeloid antigens CD33 and CLL-1 in human hematopoietic stem cells demonstrates potential…
Mindset Pharma Receives Notice of Allowance for Patent Application Covering Psilocin Derivatives for the Treatment of Central Nervous System Disorders
TORONTO, June 10, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Vincerx Pharma Presents Preclinical and Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Lymphoma at the European Hematology Association 2022 Congress
Preclinical data demonstrate VIP152 as the most selective CDK9 inhibitor compared with other CDK9 inhibitors,…
Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA) Vaccine Against SARS-CoV-2 Published in Nature Communications
— Results, which were previously pre-printed in bioRxiv, show Gritstone’s second-generation self-amplifying mRNA (samRNA) vaccine…
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or…
GSK’s RSV vaccine candidate for older adults, containing Agenus’ QS-21 STIMULON™ as part of GSK’s AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissions
First RSV vaccine candidate to show statistically significant and clinically meaningful efficacy in adults aged…
BridgeBio Pharma Affiliate Venthera Presents Preliminary Results from Clinical Trial of VT30 (BBP-681) for Venous, Lymphatic, and Venolymphatic Malformations
PALO ALTO, Calif., June 10, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio)…
AnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital Market
PHILADELPHIA, June 10, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the…
TWENTY-ONE TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 2,400,000
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF MAY 2022 VANCOUVER, BC, CANADA, June 10,…
Fulcrum Therapeutics Announces Proof-of-Concept for FTX-6058 in Sickle Cell Disease Based on Initial Data from the Ongoing Phase 1b Trial
– Achieved up to 6.3% hemoglobin F (HbF) induction in initial subjects in first cohort;…
EyePoint Pharmaceuticals to Present 12-Month Results from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD at the American Society of Retina Specialists 2022 Annual Meeting
WATERTOWN, Mass., June 10, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
Nurix Therapeutics Will Present Trial in Progress Posters for Two Clinical Programs at the 2022 Annual European Hematology Association (EHA) Congress
Posters provide background information and trial designs for ongoing clinical studies of wholly-owned NX-2127 and…
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in MELAS Patients at UMDF Mitochondrial Medicine 2022 Symposium
Data from an eight-patient, open-label study demonstrate improvements across multiple biomarkers of mitochondrial function, inflammation,…
Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
All patients treated with bezuclastinib achieved ≥50% reduction in serum tryptase, with a median reduction…
Trevena to Participate at the JMP Securities Life Sciences Conference
CHESTERBROOK, Pa., June 10, 2022 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company…